Vitamin D and parathyroid hormone in relation to bone health in Croatian women
- 71 Downloads
In N = 400 women (46.9 ± 15.5 years), the prevalence of severe (< 25 nmol/l) and mild (≥ 25 and < 50 nmol/l) 25(OH)D deficiency was 7 and 32.2%, respectively, while 60.8% women had adequate status. Serum iPTH increased (> 37.0 pg/ml) when 25(OH)D was < 46.9 nmol/l. BMD was not significantly lower in the participants with iPTH > 37.0 pg/ml.
Bone mineral density (BMD) is affected by serum 25-hydroxyvitamin D (25(OH)D) and intact parathyroid hormone (iPTH). Our objective was to analyze the association between serum 25(OH)D and iPTH and their mutual regulatory influence on BMD in women with 25(OH)D deficiency. We also attempted to establish a threshold for the serum 25(OH)D below which serum iPTH increases.
The participants were 400 generally healthy women (46.9 ± 15.5 years) recruited from local communities. BMD was measured by dual-energy X-ray absorptiometry, and serum 25(OH)D, iPTH, calcium, phosphorus, alkaline phosphatase, osteocalcin, and C-telopeptide (CTX) were analyzed from the fasting blood samples. Multivariate regression models were used to investigate the relationships among serum 25(OH)D, iPTH, and BMD.
Serum iPTH increased when 25(OH)D concentrations were below 46.9 nmol/l. Severe 25(OH)D deficiency (< 25 nmol/l) was found in 7% of the participants and was associated with significantly higher iPTH compared to participants with serum 25(OH)D ≥ 25 nmol/l. BMD was negatively associated with iPTH only in the group with severe 25(OH)D deficiency. However, BMD was not significantly lower in the participants with severe 25(OH)D deficiency compared to those with mild deficiency or with adequate status.
Our results showed that threshold level of 25(OH)D below which iPTH started to rise was 46.9 nmol/l. There was no negative impact of iPTH on BMD or bone turnover markers in women with severe 25(OH)D deficiency. This might be due to the relatively young age of our participants in whom the unfavorable effect of 25(OH)D deficiency on bone might have not yet appeared.
KeywordsVitamin D PTH Bone mineral density C-telopeptide Osteocalcin
The authors would like to thank Nada Vrkić, PhD, Associate Professor (University Hospital “Sisters of Mercy,” Zagreb) and Vesna Žižić, PhD (Children’s Hospital Zagreb), for their valuable help and laboratory analyses. The authors truly appreciate and are in debt to the participants of the study.
The study was supported by the Croatian Ministry of Science and Education (project “Diet, Homocysteine, and Bone Health” No. 058–0222411-2820; PI Irena Colić Barić).
Compliance with ethical standards
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Conflict of interest
Irena Keser, Selma Cvijetić, Martina Bituh, Ivana Rumora Samarin, Jasminka Z. Ilich, Irena Colić Barić, and Ivana Rumbak declare that they have no conflict of interest.
- 5.Carnevale V, Nieddu L, Romagnoli E, Battista C, Mascia ML, Chiodini I, Eller-Vainicher C, Frusciante V, Santini SA, La Porta M, Minisola S, Scillitani A (2010) Regulation of PTH secretion by 25-hydroxyvitamin D and ionized calcium depends on vitamin D status: a study in a large cohort of healthy subjects. Bone 47:626–630. https://doi.org/10.1016/j.bone.2010.06.013 CrossRefPubMedGoogle Scholar
- 10.Hilmi I, Sunderesvaran K, Ananda V, Sarji SA, Arumugam K, Goh KL (2013) Increased fracture risk and osteoporosis not associated with vitamin D levels in Malaysian patients with inflammatory bowel disease. J Clin Endocrinol Metab 98:2415–2421. https://doi.org/10.1210/jc.2013-1147 CrossRefPubMedGoogle Scholar
- 11.Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA (2011) The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 96:53–58. https://doi.org/10.1210/jc.2010-2704 CrossRefPubMedPubMedCentralGoogle Scholar
- 12.Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930. https://doi.org/10.1210/jc.2011-0385 CrossRefPubMedGoogle Scholar
- 16.Keser I, Ilich JZ, Vrkic N, Giljevic Z, Colic Baric I (2013) Folic acid and vitamin B12 supplementation lowers plasma homocysteine but has no effect on serum bone turnover markers in elderly women: a randomized, double-blind, placebo-controlled trial. Nutr Res 33:211–219. https://doi.org/10.1016/j.nutres.2013.01.002 CrossRefPubMedGoogle Scholar
- 18.Kaic-Rak A, Antonic K (1990) Food composition tables. Institute of Public Health of Croatia, Orbis, ZagrebGoogle Scholar
- 19.Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium (2011) In: Ross AC, Taylor CL, Yaktine AL, Del Valle HB (eds) Dietary reference intakes for calcium and vitamin D. National Academies Press (US), Washington (DC) PMID: 21796828Google Scholar
- 20.World Health Organization (1993) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO study group. WHO tech rep Ser 843, Geneva. PMID: 7941614Google Scholar
- 23.Green TJ, Skeaff CM, Rockell JEP, Venn BJ, Lambert A, Todd J, Khor GL, Loh SP, Muslimatun S, Agustina R, Whiting SJ (2008) Vitamin D status and its association with parathyroid hormone concentrations in women of childbearing age living in Jakarta and Kuala Lumpur. Eur J Clin Nutr 62:373–378. https://doi.org/10.1038/sj.ejcn.1602696 CrossRefPubMedGoogle Scholar
- 24.Hernandez JL, Olmos JM, Pariente E, Nan D, Martínez J, Llorca J, Valero C, Obregón E, Gonzalez-Macías J (2013) Influence of vitamin D status on vertebral fractures, bone mineral density, and bone turnover markers in normocalcemic postmenopausal women with high parathyroid hormone levels. J Clin Endocrinol Metab 98:1711–1717. https://doi.org/10.1210/jc.2012-3931 CrossRefPubMedGoogle Scholar
- 28.Ledger GA, Burritt MF, Kao PC, O'Fallon WM Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption. J Clin Endocrinol Metab 80:3304–3310. doi: https://doi.org/10.1210/jcem.80.11.7593443